Data / Federal grants / RFA-IP-27-035
Expanded Surveillance for Pediatric Infectious Diseases
Centers for Disease Control and Prevention - ERA (Department of Health and Human Services) expects to post this opportunity around October 30, 2026, with applications due around December 31, 2026. It lists awards of up to $1.1 million, 7 awards expected, $40 million in total.
SpecStream is the live web data engine for teams and agents. It reads every open and forecast federal opportunity on Grants.gov each morning, and this page is that reading. Describe your organization once and the grants that fit arrive in your sheet, CRM, Slack or agent as they are posted.
Key facts
- Opportunity number
- RFA-IP-27-035
- Status
- Forecast
- Posted
- July 28, 2026
- Closes
- December 31, 2026
- Award ceiling
- $1,140,000
- Award floor
- $850,000
- Expected awards
- 7
- Total funding
- $40,000,000
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Category
- Health
- Assistance listing
- 93.083 Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases
- Contact
- Jamal Bankhead · [email protected] · 404-718-4108
Who can apply
- Public and State controlled institutions of higher education
- Special district governments
- County governments
- State governments
- Native American tribal governments (Federally recognized)
- City or township governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Public housing authorities/Indian housing authorities
- Independent school districts
- Native American tribal organizations (other than Federally recognized tribal governments)
- Private institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
What the agency says
The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare. In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population. Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity. This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components. Component A – Core Component (Required) Support inpatient and emergency department pediatric surveillance Follow the standardized protocol established by CDC Optional Components Component B: Support outpatient pediatric surveillance Component C: Study immune response and infection Component D: Study immune response and immunization Recipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases. Findings of this NOFO will: Improve best practices for diagnosis and treatment protocols Inform prevention product recommendations Guide public health strategies Reduce viral illness-associated hospitalizations and healthcare utilization among children
Other open grants from the Department of Health and Human Services
| Opportunity | Status | Closes | Award ceiling | Total funding | Record |
|---|---|---|---|---|---|
| Long-term health outcomes of people living with spina bifida CDC-RFA-DD-26-0222 | Open | Oct 26 | $300,000 | $3,000,000 | grants.gov |
| GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed) RFA-HG-27-011 | Open | Oct 30 | $1,250,000 | $2,000,000 | grants.gov |
| GREGoRi Innovation Projects (U01 Clinical Trial Optional) RFA-HG-27-013 | Open | Oct 30 | $500,000 | $7,500,000 | grants.gov |
| GREGoRi Technology Integration Center (U01, Clinical Trials Optional) RFA-HG-27-012 | Open | Oct 30 | $2,250,000 | $3,000,000 | grants.gov |
| HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) PAR-27-045 | Open | Oct 30 | grants.gov | ||
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR-24-280 | Open | Nov 2 | grants.gov |
All grants open to Public colleges and universities · All grants open to Special district governments · All grants open to County governments · Everything closing in December 2026
Read from the Grants.gov API, last updated 2026-10-23. The agency's notice on Grants.gov is the official record; check it before you apply.